Laboratory Diagnosis and Monitoring of Diabetes Mellitus
Open Access
- 11 January 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 112 (5) , 665-674
- https://doi.org/10.1093/ajcp/112.5.665
Abstract
The American Diabetes Association emphasizes fasting plasma glucose (FPG) levels, rather than the oral glucose tolerance test (OGTT), to diagnose diabetes mellitus. The diagnostic cutoff for FPG is 126 mg/dL (7.0 mmol/L). A 2-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or more during an OGTT or a random plasma glucose level of 200 mg/dL (11.1 mmol/L) or more also is diagnostic of diabetes. The 100-g, 3-hour OGTT remains the “gold standard“ for gestational diabetes mellitus (GDM). Two of 4 samples exceeding cutoffs (fasting, ≥105 mg/dL [5.8 mmol/L]; 1 hour, ≥190 mg/dL [10.5 mmol/L]; 2 hours, ≥165 mg/dL [9.2 mmol/L]; 3 hours, ≥145 mg/dL [8.0 mmol/L]) indicate GDM. An effective GDM screening test is plasma glucose 1 hour after a 50-g oral glucose load. Tight control, which requires self-monitoring of blood glucose, reduces microvascular complications for patients with type 1 or type 2 diabetes. Patients with well-controlled diabetes have glycohemoglobin concentrations of 7 %A1c (0.07 A1c/A) or less. Microalbuminuria indicates early, reversible, diabetic nephropathy. The random urine albumin-creatinine ratio is a convenient effective screening test. Albumin-creatinine ratios in the 0.03 to 0.30 (g/g) range indicate microalbuminuria.Keywords
This publication has 17 references indexed in Scilit:
- Combined high blood pressure and glucose in type 2 diabetes: double jeopardyBMJ, 1998
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Determination of glycated albumin by enzyme-linked boronate immunoassay (ELBIA)Clinical Chemistry, 1998
- Management of Dyslipidemia in Adults With DiabetesDiabetes Care, 1998
- Total Serum Glycosylated Proteins in Detection and Monitoring of Gestational DiabetesDiabetes Care, 1990
- Gestational diabetes mellitus: The prevalence of glucose intolerance and diabetes mellitus in the first two months post partumAmerican Journal of Obstetrics and Gynecology, 1990
- Evaluation and performance characteristics of a novel ELISA using monoclonal antibody to glycated albuminClinica Chimica Acta; International Journal of Clinical Chemistry, 1989
- Evaluation of Albumin Excretion Rate in Overnight Versus 24-h UrineDiabetes Care, 1989
- Production and characterization of monoclonal antibodies against human glycoalbuminJournal of Immunological Methods, 1989